Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1805794
rs1805794
NBN
0.060 GeneticVariation BEFREE Using the multifactor dimensionality reduction method, we found a model of gene-gene interactions associated with the risk of lung cancer: NBS1 (rs1805794)-XRCC1 (rs25487)-hOGG1 (rs1052133)-XPG (rs17655). 31584889

2019

dbSNP: rs1805794
rs1805794
NBN
0.060 GeneticVariation BEFREE The CC genotype of NBS1 Glu185Gln may increase lung cancer risk only for males and smokers and may serve as a practical marker for early detective and predictive purposes of lung cancer. 28476809

2017

dbSNP: rs1805794
rs1805794
NBN
0.060 GeneticVariation BEFREE The meta-analysis further confirmed the association between the variant rs1805794G>C and lung cancer</span> risk, that compared with the GG genotype, the carriers of C genotypes had a 1.30-fold risk of cancer (95% CI=1.14-1.49, P=8.49×10(-5)). 25771871

2014

dbSNP: rs1805794
rs1805794
NBN
0.060 GeneticVariation BEFREE The functional polymorphism of NBS1 p.Glu185Gln is associated with an increased risk of lung cancer in Chinese populations: case-control and a meta-analysis. 25771871

2014

dbSNP: rs1805794
rs1805794
NBN
0.060 GeneticVariation BEFREE This meta-analysis supports that there is an association between NBS1 Glu185Gln</span> polym</span>orphism and lung cancer</span> risk. 23275190

2013

dbSNP: rs1805794
rs1805794
NBN
0.060 GeneticVariation BEFREE These associations were: two SNPs rs1799793 and rs13181 in the ERCC2 gene and lung cancer (recessive model) and rs1805794 in the NBN gene and bladder cancer (dominant model). 21864546

2012

dbSNP: rs1805794
rs1805794
NBN
0.060 GeneticVariation BEFREE We examined the association between two common NBS1 polymorphisms (Leu34Leu, Gln185Glu) and lung cancer risk in a population-based case-control study in Xuan Wei, China. 15921821

2005

dbSNP: rs13312986
rs13312986
0.010 GeneticVariation BEFREE No significant association was observed for rs13312986 and rs14448; we only found that the rs2735383CC genotype had a significantly increased risk of lung cancer under a recessive genetic model in the total 1559 cases versus 1679 controls (odds ratio = 1.40, 95% confidence interval = 1.18-1.66, P = 0.0001) when compared with GG or GC genotypes; the rs2735383CC genotype carriers had lower messenger RNA and protein expression levels in tumor tissues than those of other genotypes as quantitative polymerase chain reaction and western blot shown. 22114071

2012

dbSNP: rs14448
rs14448
0.010 GeneticVariation BEFREE No significant association was observed for rs13312986 and rs14448; we only found that the rs2735383CC genotype had a significantly increased risk of lung cancer under a recessive genetic model in the total 1559 cases versus 1679 controls (odds ratio = 1.40, 95% confidence interval = 1.18-1.66, P = 0.0001) when compared with GG or GC genotypes; the rs2735383CC genotype carriers had lower messenger RNA and protein expression levels in tumor tissues than those of other genotypes as quantitative polymerase chain reaction and western blot shown. 22114071

2012

dbSNP: rs2735383
rs2735383
0.010 GeneticVariation BEFREE Our data suggested that the rs2735383G>C variation contributes to an increased risk of lung cancer by diminishing gene's expression through binding of microRNA-629 to the polymorphic site in the 3'-UTR of NBS1 gene. 22114071

2012

dbSNP: rs1063054
rs1063054
0.010 GeneticVariation BEFREE Additionally, positive associations were found for rs709816 with bladder cancer (OR(adj) = 4.2, 95% CI: 1.4, 12) and rs1063054 with lung cancer (OR(adj) = 1.6, 95% CI: 1.0, 2.3). 20478923

2010

dbSNP: rs709816
rs709816
NBN
0.010 GeneticVariation BEFREE Additionally, positive associations were found for rs709816 with bladder cancer (OR(adj) = 4.2, 95% CI: 1.4, 12) and rs1063054 with lung cancer (OR(adj) = 1.6, 95% CI: 1.0, 2.3). 20478923

2010